PRESS RELEASE published on 05/30/2023 at 07:30, 2 years 8 months ago Formycon reports results for the first quarter 2023
PRESS RELEASE published on 05/10/2023 at 07:30, 2 years 8 months ago Formycon Announces Participation in International Investor Conferences in Q2/2023
PRESS RELEASE published on 04/27/2023 at 07:30, 2 years 9 months ago Formycon publishes results for financial year 2022
PRESS RELEASE published on 04/25/2023 at 07:00, 2 years 9 months ago Formycon announces successful results of Phase I clinical trial for ustekinumab biosimilar candidate FYB202 and concludes clinical development
PRESS RELEASE published on 02/07/2023 at 07:30, 3 years ago Enno Spillner appointed Chief Financial Officer (CFO) of Formycon AG
PRESS RELEASE published on 02/06/2023 at 07:30, 3 years ago Aflibercept Biosimilar Candidate FYB203 shows comparable efficacy to the reference product Eylea®1 in Phase III Study
PRESS RELEASE published on 02/02/2023 at 08:00, 3 years ago Formycon and Fresenius Kabi conclude global commercialization partnership for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)
PRESS RELEASE published on 02/02/2023 at 07:30, 3 years ago EQS-Adhoc: Formycon AG announces result of private placement and sets placement price for the new shares from the capital increase
PRESS RELEASE published on 02/01/2023 at 23:30, 3 years ago EQS-Adhoc: Formycon AG upsizes capital increase from authorized capital following strong demand
PRESS RELEASE published on 02/01/2023 at 17:40, 3 years ago EQS-Adhoc: Formycon AG announces global license agreement with Fresenius Kabi for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)
Published on 02/09/2026 at 15:00, 3 hours 38 minutes ago Gungnir Resources Inc. Announces Management And Board Changes
Published on 02/09/2026 at 14:15, 4 hours 23 minutes ago White Gold Corp. Appoints Seasoned Mining Executive Donovan Pollitt as Strategic Advisor
Published on 02/09/2026 at 14:00, 4 hours 38 minutes ago Paymetrex Secures First U.S. License Payment
Published on 02/09/2026 at 14:00, 4 hours 38 minutes ago Geophysics Converge Ahead of Colosseum Deeper Drill Program
Published on 02/09/2026 at 13:00, 5 hours 38 minutes ago Eagle Plains' Partner Refined Energy Corp. Mobilizes Geophysical Team to the Dufferin West Project, Saskatchewan
Published on 02/09/2026 at 17:52, 46 minutes ago EQS-Adhoc: GESCO SE: Burden from the insolvency of a contractual partner
Published on 02/09/2026 at 17:28, 1 hour 10 minutes ago XTPL intends to raise capital through a share offering; the goal for 2026 is next industrial implementation and launch of ODRA sales
Published on 02/09/2026 at 17:24, 1 hour 14 minutes ago EQS-Adhoc: net digital AG Likely Exceeds 2025 Annual Forecast for Revenue and Earnings
Published on 02/09/2026 at 15:58, 2 hours 40 minutes ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc
Published on 02/09/2026 at 18:00, 38 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 53 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 53 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026